Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Agenus Inc (NQ: AGEN )

3.200 USD +0.040 (+1.27%)
Official Closing Price Updated: 7:39 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Agenus Inc

< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
Cancer Drug Development Shows That Government and Private Sector can Work Together
Financialnewsmedia.com News Commentary 
From PR Newswire
Cancer Drug Development Shows That Government and Private Sector Can Work Together
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Agenus to Launch the First Asset-Backed Digital Security Offering in Healthcare
- The Biotech Electronic Security Token (BEST) is designed to be an innovative and transformative way to finance drug development through increasing liquidity, minimizing dilution, and improving... 
From PR Newswire
Atomic Capital Kicks off Investor Forum Announcing Digital Offering for NASDAQ-Traded Biotech Group, Agenus Inc.
A critical milestone for the burgeoning digital securities ecosystem and a major innovation for financing drug development 
From PR Newswire
Agenus Closes $150 Million Immuno-Oncology Transaction with Gilead
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune modulating antibodies, cancer vaccines, and adoptive cell therapies1, today announced the closing of its immuno-oncology... 
From PR Newswire
48 Biggest Movers From Yesterday
Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares climbed 49.3 percent to close at $2.12 on Thursday after acquiring IIU, a ... 
Tags Markets LPTX Movers & Shakers
From Benzinga
Here's Why Gilead Sciences Lost $12.1 Billion in December
Another bad month for the biotech industry weighed this stock down last month. 
Tags Market News GILD AGEN
From Motley Fool
Selexis Expands Strategic Immuno-Oncology Alliance with Agenus
Selexis SA, a pioneering life sciences company and a global leader in mammalian cell line generation technology, announced today that it has signed additional commercial license agreements (CLAs) with... 
From Business Wire News Releases
Research Report Identifies Conagra Brands, W.R. Grace, International Flavors & Fragrances, Spirit Airlines, Sunstone Hotel Investors, and Agenus with Renewed Outlook — Fundamental Analysis, Calculatin
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Conagra Brands Inc.... 
From GlobeNewswire News Releases
Why Agenus Stock Is Spiking Today
Eli Lilly's acquisition of Loxo Oncology lit a fire underneath the cancer immunotherapy company today.. 
Tags LOXO GILD MRK
From Motley Fool
All the Pre-JPM News Healthcare Investors Need to Know
The Super Bowl of biotech kicked off early for these companies. 
Tags BIIB Market News CELG
From Motley Fool
58 Biggest Movers From Yesterday
Gainers OHR Pharmaceutical Inc (NASDAQ: OHRP) shares jumped 61.36 percent to close at $0.1775 on Thursday after announcing a ... 
Tags BEDU Top Gainers IZEA
From Benzinga
Why Celgene, Agenus, and Incyte Jumped Today
Biotech was a popular sector today. Find out why. 
Tags AGEN INCY CELG
From Motley Fool
Here's Why Agenus Shares Rose as Much as 13.5% Today
The Bill & Melinda Gates Foundation helped to kick-start a vaccine manufacturing partnership for the small-cap biopharma. 
Tags AGEN Market News
From Motley Fool
Agenus Awarded Grant to Enable QS-21 Innovations
- Bill & Melinda Gates Foundation invests ~$1M to develop novel technology for QS-21 
From PR Newswire
33 Stocks Moving In Wednesday's Mid-Day Session
Gainers Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) shares surged 41.4 percent to $7.00 after rising 15.12 percent on ... 
Tags NFEC HYGS SFET
From Benzinga
3 Biotech Stocks That Are Too Cheap to Ignore
These three biotech stocks could prove to be outstanding bargains for long-term investors. 
Tags AMRN Market News VKTX
From Motley Fool
August 2019 Options Now Available For Agenus (AGEN)
Investors in Agenus Inc (AGEN) saw new options begin trading today, for the August 2019 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time... 
Tags Stocks
From Market News Video
2 Beaten-Down Biotech Stocks That Look Like Bargains Now
Market beatings for very different drugmakers may have gone too far. 
Tags AGEN GILD Market News
From Motley Fool
Thinking about buying stock in Agenus Inc., BlackBerry Limited, Caesars Entertainment Corp., New Age Beverages Corp., or Twitter, Inc.?
InvestorsObserver issues critical PriceWatch Alerts for AGEN, BB, CZR, NBEV, and TWTR. 
From PR Newswire
60 Biggest Movers From Yesterday
Gainers Inpixon (NASDAQ: INPX) shares climbed 37.12 percent to close at $4.10 on Thursday after the company announced it is on ... 
Tags EDAP SHLO MDLY
From Benzinga
Mid-Afternoon Market Update: Dow Tumbles 400 Points; DBV Technologies Shares Plummet
Toward the end of trading opening Thursday, the Dow traded down 1.71 percent to 22,923.29 while the NASDAQ declined 1.62 percent to ... 
Tags WBA Market News INPX
From Benzinga
Why Agenus Stock Is Soaring Today
A major development deal with Gilead Sciences sent Agenus's shares rocketing higher today. 
Tags AGEN GILD Market News
From Motley Fool
46 Stocks Moving In Thursday's Mid-Day Session
Gainers Inpixon (NASDAQ: INPX) shares climbed 57.1 percent to $4.6968 after the company announced it is on track to ship record ... 
Tags General DGLY Losers
From Benzinga
Mid-Day Market Update: Crude Oil Down Over 3%; Agenus Shares Spike Higher
Midway through trading opening Thursday, the Dow traded down 0.57 percent to 23,189.82 while the NASDAQ declined 0.4 percent to ... 
Tags Commodities Eurozone Markets
From Benzinga
Mid-Morning Market Update: Markets Mostly Lower; Walgreens Earnings Top Expectations
Following the market opening Thursday, the Dow traded down 0.38 percent to 23,235.56 while the NASDAQ climbed 0.18 percent to 6,649.06. ... 
Tags Intraday Update Markets AIMT
From Benzinga
Gilead, Agenus sign deal to develop immuno-oncology therapies
Gilead Sciences Inc has inked a collaboration agreement with Agenus Inc for the development and marketing of up to five novel immuno-oncology therapies. 
Tags companyNews
From Reuters: Company News
Gilead And Agenus Enter into Collaboration to Develop Immuno-Oncology Therapies
-- Agenus Webcast and Conference Call Scheduled for Today at 8:30a.m.ET -- 
From PR Newswire
Gilead and Agenus Enter Into Collaboration to Develop Immuno-Oncology Therapies
Gilead Sciences, Inc. (NASDAQ: GILD) and Agenus Inc. (NASDAQ: AGEN) announced today the companies have entered into an immuno-oncology (I-O) partnership focused on the development and commercialization... 
From Business Wire News Releases
How The Pieces Add Up: IEIH Headed For $31
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.